Compare · AONC vs CHE
AONC vs CHE
Side-by-side comparison of American Oncology Network Inc. (AONC) and Chemed Corp (CHE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AONC and CHE operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE carries a market cap of $6.78B.
- CHE has hit the wire 1 time in the past 4 weeks while AONC has been quiet.
- CHE has more recent analyst coverage (6 ratings vs 0 for AONC).
- Company
- American Oncology Network Inc.
- Chemed Corp
- Price
- $2.25+25.00%
- $510.52+1.67%
- Market cap
- -
- $6.78B
- 1M return
- -
- +14.12%
- 1Y return
- -
- +9.40%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 0
- 1
- Recent ratings
- 0
- 6
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Latest AONC
- SEC Form 10-K filed by American Oncology Network Inc.
- Cancer and Blood Specialists of Arizona and American Oncology Network Welcome Dr. Ronak Rakesh Shah
- SEC Form 15-15D filed by American Oncology Network Inc.
- Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting
- Amendment: American Oncology Network Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- American Oncology Network Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- American Oncology Network's Specialty Pharmacy Achieves ACHC Reaccreditation
- SEC Form EFFECT filed by American Oncology Network Inc.
- SEC Form S-8 POS filed by American Oncology Network Inc.
- SEC Form POS AM filed by American Oncology Network Inc.
Latest CHE
- Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29
- SEC Form 11-K filed by Chemed Corp
- Director Lindell Andrea R sold $602,554 worth of Capital Stock (1,347 units at $447.33), decreasing direct ownership by 23% to 4,578 units (SEC Form 4)
- Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas
- Director Walsh George J Iii sold $218,915 worth of Capital Stock (500 units at $437.83), decreasing direct ownership by 13% to 3,209 units (SEC Form 4)
- Chemed Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Walsh George J Iii was granted 386 units of Capital Stock, increasing direct ownership by 12% to 3,709 units (SEC Form 4)
- Director Mount John Meredith Jr. was granted 386 units of Capital Stock, increasing direct ownership by 42% to 1,316 units (SEC Form 4)
- Director Mccarthy Eileen P was granted 386 units of Capital Stock, increasing direct ownership by 45% to 1,241 units (SEC Form 4)
- Director Lindell Andrea R was granted 386 units of Capital Stock, increasing direct ownership by 7% to 5,925 units (SEC Form 4)